Who owns Syros Pharmaceuticals?

Top investors of Syros Pharmaceuticals stock

Who bought or sold Syros Pharmaceuticals this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of
ARK Investment Management 8.5M $91M 44% Jun 2020
FMR 6.6M $71M 5% Jun 2020
Sumitomo Mitsui Trust Holdings 4.7M $50M -4% Jun 2020
Nikko Asset Management Americas 4.7M $39M -4% Jun 2020
Flagship Ventures Management 2.9M $31M 0% Jun 2020
BlackRock 2.8M $17M -2% Mar 2020
Vanguard Group 1.9M $20M 6% Jun 2020
Samsara BioCapital 1.6M $16M -9% Jun 2020
Point72 Asset Management 1.5M $16M -33% Jun 2020
State Street Corporation 845k $9.0M 29% Jun 2020
Jpmorgan Chase & Co 793k $0 -10% Jun 2020
Baker Bros. Advisors 690k $7.4M 0% Jun 2020
Geode Capital Management 564k $6.0M 13% Jun 2020
Dimensional Fund Advisors 564k $6.0M 0% Jun 2020
Portolan Capital Management 499k $5.3M -3% Jun 2020
Northern Trust 492k $5.3M 21% Jun 2020
Artal Group 490k $5.2M -3% Jun 2020
Arch Venture Corp 400k $4.3M -87% Jun 2020
Sio Capital Management 273k $2.9M -42% Jun 2020
Charles Schwab Investment Management 251k $2.7M 22% Jun 2020
Two Sigma Investments 247k $2.6M 100% Jun 2020
D. E. Shaw & Co 232k $2.5M 174% Jun 2020
Redmile Group 212k $2.3M 0% Jun 2020
Nuveen Asset Management 203k $2.2M 47% Jun 2020
Two Sigma Advisers 182k $1.9M 127% Jun 2020
Millennium Management 153k $1.6M 100% Jun 2020
CalPERS 95k $1.0M 171% Jun 2020
Martingale Asset Management 92k $982k 100% Jun 2020
Alyeska Investment Group 86k $918k 100% Jun 2020
Thomas Stevens, CFA" 83k $886k 77% Jun 2020
Wells Fargo & Company 83k $886k 265% Jun 2020
Citigroup 71k $752k 458% Jun 2020
Jacobs Levy Equity Management 67k $719k 5% Jun 2020
Goldman Sachs Group 63k $669k 22% Jun 2020
California State Teachers Retirement System 63k $667k 19% Jun 2020
ALPS Advisors 62k $664k 100% Jun 2020
Renaissance Technologies 58k $621k 100% Jun 2020
Acadian Asset Management 56k $598k 100% Jun 2020
Bessemer 55k $585k 100% Jun 2020
State of Wisconsin Investment Board 54k $570k -20% Jun 2020
Alliancebernstein 49k $524k 24% Jun 2020
Rhumbline Advisers 49k $522k 24% Jun 2020
New York State Common Retirement Fund 40k $431k 29% Jun 2020
Virtus ETF Advisers 40k $422k 100% Jun 2020
AQR Capital Management 39k $417k 167% Jun 2020
PDT Partners 35k $377k 0% Jun 2020
American International 25k $271k 24% Jun 2020
Manufacturers Life Insurance Company 25k $266k 9% Jun 2020
Marshall Wace 25k $261k 100% Jun 2020
Morgan Stanley 24k $252k 330% Jun 2020
Barclays 23k $244k 99% Jun 2020
Susquehanna International 23k $242k -33% Jun 2020
SG Americas Securities 23k $241k 63% Jun 2020
T. Rowe Price Associates 23k $240k -74% Jun 2020
Florida State Board of Administration 21k $228k 100% Jun 2020
Deutsche Bank Aktiengesellschaft 21k $219k 77% Jun 2020
Mitsubishi UFJ Asset Management 21k $221k 100% Jun 2020
Cubist Systematic Strategies 19k $203k 11393% Jun 2020
Bank of America Corporation 19k $202k -12% Jun 2020
MetLife Investment Advisors 17k $184k 0% Jun 2020
Ing Investment Management 15k $157k -21% Jun 2020
Springbok Capital Management 14k $151k 100% Jun 2020
UBS Group 13k $139k -22% Jun 2020
ProShare Advisors 13k $138k 100% Jun 2020
Citadel Advisors 13k $134k 100% Jun 2020
Metropolitan Life Insurance Company 13k $133k 2% Jun 2020
Dynamic Technology Lab Private 12k $131k 100% Jun 2020
Resources Investment Advisors 10k $107k 100% Jun 2020
Russell Investments 9.0k $95k 325% Jun 2020
Tower Research Capital 8.3k $89k 100% Jun 2020
Legal & General Group 6.8k $73k 20% Jun 2020
Royal Bank of Canada 6.1k $65k 3272% Jun 2020
Summit Investment Advisors 3.7k $39k 41% Jun 2020
Bank Of Montreal 3.3k $40k 100% Jun 2020
Bnp Paribas Arbitrage, Snc 3.1k $33k -71% Jun 2020
Private Advisor 300.00 $3.0k 100% Jun 2020
Daiwa Securities Group 270.00 $2.0k 0% Jun 2020
Group One Trading 200.00 $2.0k 100% Jun 2020

Who sold out of Syros Pharmaceuticals?

Fund or Company Name Date Sold Shares Held Valued At
Deerfield Management Company Mar 2020 1.3M $7.5M
Invesco Mar 2020 90k $550k
AlpInvest Partners B.V. Mar 2020 15k $89k
Squarepoint Ops Mar 2020 12k $68k
Victory Capital Management Mar 2020 3.9k $23k

Funds that own Syros Pharmaceuticals also own: